Irbesartan inhibits human T‐lymphocyte activation through downregulation of activator protein‐1

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1983 • 52,849 citations

Atherosclerosis — An Inflammatory Disease

1999 • 21,494 citations

AP-1 function and regulation

1997 • 2,833 citations

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

1994 • 2,753 citations

Requirement for Generation of H ₂ O ₂ for Platelet-Derived Growth Factor Signal Transduction

1995 • 2,505 citations

Angiotensin II receptors and angiotensin II receptor antagonists.

1993 • 1,843 citations

H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

1993 • 1,330 citations

Cellular and molecular mechanisms of endothelial cell dysfunction.

1997 • 1,064 citations

Matrix Metalloproteinases and Cardiovascular Disease

1995 • 873 citations

Oxidative Stress as a Regulator of Gene Expression in the Vasculature

1999 • 810 citations

p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle Cells

1996 • 768 citations

Detection of activated T lymphocytes in the human atherosclerotic plaque.

1989 • 739 citations

Role of the CD28 receptor in T-cell activation

1990 • 684 citations

Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

1991 • 669 citations

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

1994 • 644 citations

Vascular Inflammation and the Renin-Angiotensin System

2002 • 570 citations

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.

1989 • 558 citations

Transfer of CD4 ⁺ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice

2000 • 546 citations

Cytotoxic mechanism of tumor necrosis factor‐α

1990 • 539 citations

Involvement of Reactive Oxygen Species in Cytokine and Growth Factor Induction of c-fos Expression in Chondrocytes

1995 • 538 citations

Tumor Necrosis Factor-α Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway

2000 • 512 citations

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

1994 • 511 citations

CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.

1995 • 489 citations

Detection and localization of tumor necrosis factor in human atheroma

1990 • 453 citations

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

1994 • 408 citations

The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains.

1994 • 351 citations

In Vivo Downregulation of T Helper Cell 1 Immune Responses Reduces Atherogenesis in Apolipoprotein E-Knockout Mice

2001 • 288 citations

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells.

1989 • 265 citations

Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis.

1991 • 235 citations

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1991 • 215 citations

Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human Monocytes

1999 • 195 citations

Role of immunocompetent cells in nonimmune renal diseases

2001 • 187 citations

Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1

2002 • 185 citations

Allele-Specific Regulation of Matrix Metalloproteinase-12 Gene Activity Is Associated With Coronary Artery Luminal Dimensions in Diabetic Patients With Manifest Coronary Artery Disease

2000 • 183 citations

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells

1998 • 177 citations

Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.

1995 • 176 citations

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

2001 • 174 citations

Modulation of transcription factor NFχB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply

1995 • 168 citations

Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis

1993 • 155 citations

CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4⁺ T cells and induce similar patterns of cytokine secretion in vitro

1995 • 152 citations

The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice

1997 • 138 citations

Angiotensin II Induces Tumor Necrosis Factor Biosynthesis in the Adult Mammalian Heart Through a Protein Kinase C–Dependent Pathway

2002 • 134 citations

RelA Is a Potent Transcriptional Activator of the CD28 Response Element within the Interleukin 2 Promoter

1995 • 131 citations

Angiotensin II and gene expression in the kidney

1998 • 128 citations

Differential expression and function of CD80 (B7‐1) and CD86 (B7‐2) on human peripheral blood monocytes

1996 • 127 citations

Inhibition of Neointima Hyperplasia of Mouse Vein Grafts by Locally Applied Suramin

1999 • 124 citations

Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo

2002 • 119 citations

Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family.

1999 • 107 citations

Expression of the Macrophage Scavenger Receptor in Atheroma

1995 • 106 citations

Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes

2001 • 103 citations

Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells

1998 • 102 citations

The effect of renin–angiotensin system inhibitors on pro‐ and anti‐inflammatory cytokine production

1998 • 98 citations

Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice

2001 • 93 citations

Biomechanical Strain Induces Class A Scavenger Receptor Expression in Human Monocyte/Macrophages and THP-1 Cells

2001 • 92 citations

The New Angiotensin II Receptor Antagonist, IrbesartanPharmacokinetic and Pharmacodynamic Considerations

1997 • 89 citations

Atherogenic Diets Enhance Endotoxin-Stimulated Interleukin-1 and Tumor Necrosis Factor Gene Expression in Rabbit Aortae ,

1992 • 81 citations

Captopril Prevents Experimental Autoimmune Myocarditis

2003 • 76 citations

Wine Phenolic Antioxidants Inhibit AP-1 Transcriptional Activity

2001 • 74 citations

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease

2001 • 70 citations

Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.

2000 • 69 citations

Induction of vascular cell adhesion molecule-1 by low-density lipoprotein

1996 • 68 citations

Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure

1999 • 68 citations

Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis

1999 • 65 citations

Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells A potential link between aging, smooth muscle cell proliferation and atherosclerosis

2000 • 53 citations

PLANT ALKALOID TETRANDRINE AND ITS ANALOG BLOCK CD28-COSTIMULATED ACTIVITIES OF HUMAN PERIPHERAL BLOOD T CELLS

1999 • 52 citations

Immune Mechanisms in Atherogenesis

1994 • 49 citations

Carvedilol, a new antioxidative β-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-κB activity

2003 • 41 citations

Angiotensin II AT1-Receptor Blockade Inhibits Monocyte Activation and Adherence in Transgenic (mRen2)27 Rats

1999 • 34 citations

Down-regulation of c-jun N-terminal kinase-activator protein-1 signaling pathway by Ginkgo biloba extract in human peripheral blood T cells

2003 • 31 citations

Tumor Necrosis Factor- α –Induced Activating Protein-1 Activity Is Modulated by Nitric Oxide–Mediated Protein Kinase G Activation

2000 • 30 citations

Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.

2002 • 30 citations

Captopril inhibits the production of tumor necrosis factor-α by human mononuclear cells in patients with congestive heart failure

2001 • 26 citations

Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension

2001 • 23 citations

Hydrogen peroxide and tumour necrosis factor-α induce NF-κB-DNA binding in primary human T lymphocytes in addition to T cell lines

2001 • 16 citations

T-Lymphocyte and Plasma Angiotensin-Converting Enzyme Activity During Enalapril and Losartan Administration in Humans

2001 • 10 citations

Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells

2001 • 2 citations